Madopar (levodopa) Data Sheet (DS) - Medsafe
MADOPAR 160202 2 A No. 1 size capsule with a “ROCHE” imprint, an opaque caramel coloured body and an opaque powder-blue cap. Each capsule contains: 200mg levodopa and 57 mg benserazide hydrochloride
Download Madopar (levodopa) Data Sheet (DS) - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzTreatment of recurrent, platinum-resistant disease: 10 mg/kg body weight given once every 2 weeks when administered in combination with one of …
Section 1: Legislation - Medsafe Home Page
medsafe.govt.nzSection 2: Overview of Regulation of Clinical Trials in New Zealand . Section summary Under Section 30 of the Medicines Act 1981, approval from the Director-General of
Section 1: Legislation relating to the labelling - …
medsafe.govt.nzPart 5, Ed 1.6 Page 2 of 18 . Section 1: Legislation relating to the labelling of medicines and related products Section summary This section lists the legislation regulating the labelling of medicines and related products.
NEW ZEALAND DATA SHEET VERMOX® - …
medsafe.govt.nzNEW ZEALAND DATA SHEET VERMOX® Vermox® Page 2 of 7 For control of enterobiasis Adults and children 2-12 years: 1 Vermox tablet (100 mg) or 5 mL of suspension (100 mg) is given.
Guideline on the Regulation of Therapeutic …
medsafe.govt.nzGuideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0
Clonazepam: oral drops (2.5 mg/ml); injection (1 mg).
medsafe.govt.nz2. you have severe and chronic lung disease 3. you have severe liver disease 4. you have an addiction to drugs or alcohol 5. the package is torn or shows signs of tampering
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzNEW ZEALAND DATA SHEET 5 Hypnovel 170717 Medical history of alcohol or drug abuse Hypnovel should be avoided in patients with a medical history of alcohol or drug abuse.
SCHEDULE OF FEES (effective from 1 July 2018)
medsafe.govt.nzPage 1 of 10. SCHEDULE OF FEES (effective from 1 July 2018) • All fees listed are GST inclusive. • More detailed descriptions of the type of application or change to which a fee applies can be
Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets
medsafe.govt.nz1 Nortriptyline NRIM 09052013 NEW ZEALAND DATA SHEET Nortriptyline NRIM . Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets . This product may not be interchangeable with similar products on the New Zealand market
2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3 ...
medsafe.govt.nz1. PRODUCT NAME LOSARTAN ACTAVIS (Losartan Potassium 12.5mg, 25mg, 50mg and 100mg Tablets) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains: 12.5 mg losartan potassium 25 mg losartan potassium 50 mg losartan potassium 100mg losartan potassium . For the full list of excipients, see section 6.1. 3. …
Related documents
A case of Inherited Unconjugated …
iosrjournals.orgA case of Inherited Unconjugated Hyperbilirubinemiaforan incidental surgery: Anesthetic www.iosrjournals.org 18 | Page
Trismus: Aetiolog Diffy, erential Diagnosis and …
www.exodontia.info88 Dental Update – March 2002 ORAL SURGERY Abstract: Trismus is a problem commonly encountered by the dental practitioner. It has a number of potential causes, and its treatment will depend on the cause. This article discusses the primary causes of this condition and the various treatments
Objectif : Les anesthésiques - IFSI DIJON
www.ifsidijon.infoLes anesthésiques IFSI 9 septembre 2014 Mathieu BOULIN Définition Objectif :-conduire àun état de sommeil (hypnotiques)-obtenir une analgésie (analgésiques)
ADRENALINE INJECTION 1:10,000 - Medsafe Home …
www.medsafe.govt.nzFurther bolus doses or continuous infusion may be required to maintain an adequate blood pressure after the patient generated pulse has returned.
HALOTHANE- MATERIAL SAFETY DATA SHEET
www.megs.ca11. TOXICOLOGICAL INFORMATION-----Up to Table of Contents HALOTHANE: IRRITATION DATA: 100 mg eyes-rabbit severe TOXICITY DATA: 29000 ppm inhalation-rat LC50; 5680 mg/kg oral-rat LD50
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.suprane.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUPRANE safely and effectively. See …
Key Points - WHO
www.who.intESSENTIAL HEALTH TECHNOLOGIES CLINICAL PROCEDURES HTP/EHT/CPR 14 Practical anaesthesia Key Points